From: Genus Curcuma: chemical and ethnopharmacological role in aging process
Curcuma species | Common name | Biological activity | Experiment/test | Dosage/concentration | Main findings/results | Reference(s) |
---|---|---|---|---|---|---|
C. caesia | Black turmeric | Antioxidant | DPPH α-amylase inhibition | 18μg/mL for the DPPH assay and 26μg/mL for the α-amylase inhibition assay | DPPH (IC50 = 299.18μg/mL) α-amylase inhibitory (IC50 = 50.16μg/mL) | [88] |
DPPH | 48 μg/mL | (IC50 = 1.487μg/mL) | [89] | |||
C. aromatica | Wild turmeric | DPPH, lipid peroxidation assay and protein denaturation inhibition | 50 µl extract | DPPH (IC50 = 0.55 ± 0.02mg/mL) Lipid peroxidation (IC50 = 0.60 ± 0.10mg/mL). Protein denaturation inhibition (65.97 ± 4.68%) | [90] | |
C. xanthorrhiza | Javanese turmeric | DPPH | 1ml of extract | (IC50 = 0.177–0.615mg/mL) | [91] | |
DPPH, CUPRAC (Cupric ion Reducing Antioxidant Capacity), lipase enzyme inhibition and BCB (β-Carotene Bleaching) methods | – | DPPH (IC50 = 255.36 ± 1.87 µg/mL), CUPRAC (IC50 = 150.42 ± 13.71 µmol QE quercetin/100 g), and Lipase inhibition (115.79 ± 3.44 µg/mL) and BCB (IC50 = 232.15 ± 1.99 µg/mL) | [92] | |||
C. longa (C. domestica) | ––- | Reducing power assay and the cyclic voltammetry technique | 2 mL extract extract, 2.50 mL of phosphate buffer (0.20 M, pH = 6.60) was added followed by addition of 2.50 mL of 1% K3Fe(CN)6 | Reducing power = 45.632 ± 2.026 | [93] | |
C. longa [variety: Ryudai gold (RD) and Okinawa ukon], C. xanthorrhiza, C. aromatica, C. amada and C. zedoaria | ––- | DPPH, ORAC and 2-deoxyribose(2-DR) oxidation assay | 80 μL samples at different concentrations (10, 25 and 50 μg/mL) | DPPH (IC50 = 26.4μg/mL), ORAC (14,090μmol Trolox equivalent/g extract), reducing power absorbance (0.33) and hydroxyl radical scavenging activity (IC50 = 7.4μg/mL) | [94] | |
C. longa | ––- | Neuroprotective | Cholinesterase and glycogen synthasekinase-3β inhibition | 1 mg/mL extract reached 4.2 μg/mL after dilution with buffer | Weak to moderate acetylcholinesterase and butyryl cholinesterase inhibition | [95] |
C. amada | Mango ginger | Brain of F1 progeny of Danio rerio (Zebrafish) which has been gestationally exposed to the neurotoxicant nickel chloride | 150µg | ↓Anxiety behavior in the F1 progeny of exposed fish co-treated C. amada Marked improvement in the memory and learning pattern in C. amada-treated fishes | [96] | |
Curcumin | ––- | Diabetic rats’ brains | – | ↓Malondialdehyde level in the brain of diabetic rats. Protective effects against glutamate neurotoxicity in the male albino rats Corrected cognitive impairment ↓Apoptosis in the cerebral cortex | [10] | |
C. aromatica | Wild turmeric | Anti-inflammatory | Effect on inflammatory mediators | 200 μg/mL extract | Inhibit in NF‐κB activity (IC50 = 46.9 ± 8.6) | [97] |
C. longa | ––- | Albumin denaturation, proteinase inhibitory activity, membrane stabilization and anti-lipoxygenase activity | 0.25 mL extract in 2 M borate buffer (pH 9.0) | Significantly ↓ albumin denaturation and proteinase activity Stabilized RBCs membrane from haemolysis ↓Lipoxygenase activity | [98] | |
C. singularis Gagnep | ––- | Cytotoxic and anti-proliferative | In vitro cytotoxicity against different gastric cancer cell lines | 50 μg/mL | Cytotoxicity was concentration-dependent. ↑Bax/Bcl-2 ratio ↑ release of cytochrome C Activation of caspase-3/-7, caspase-9 and cleavage | [99] |
C. longa (Curcumin in tiny nano-molecules) | ––- | mTOR in breast cancer growth | – | Curcumin can act as an anti-cancer drug especially when using lipid-coated nano-particles for better drug delivery | ||
C. longa (Curcumin-quercetin in lipid carrier) | ––- | Oral squamous cell carcinoma | – | ↓AKT/PI3K signaling pathway ↓Cyclin A/D/E expression Helps G1/G2/M phase arrest Nanostructured lipid-carriers improved loading capacity of the drug combination and improve site-specific targeting | [102] | |
C. aeruginosa Roxb | temu hitam | Cytotoxic and anti-proliferative | A-549 human lung adenocarcinoma and HeLa cell lines | 5, 10, 20, 40, 80 & 100 µg/ml extract | ↑Caspase 3 and 8 expressions Apoptosis in cancer cells | [66] |
C. longa and C. aromatica | ––- | Human cervical cancer cell line (MTT assay) | 6.25, 12.5, 25, 50 & 100uL/mL extract | Cytotoxic activity (IC50 = 6.25-100ul) | [103] | |
C. caesia Roxb | Black turmeric | 2,3,5-Triphenyltetrazolium chloride (TTC), 2',7'-dichlorofluorescein diacetate (DCFDAH 2) assays and in vitro DNA protection assay | 2.5, 5 and 10 µg/ml extract | ↓Oxidative DNA damage in vitro | [104] | |
C. amada | Mango ginger | Immuno-cyto-chemical analysis (expression of apoptosis-associated proteins Bax, Bcl-2, and p53) | – | ↑Pro-apoptotic proteins p53and Bax expression in cancer cells ↓Anti-apoptotic protein Bcl-2 expression | [105] | |
C. longa | ––- | Anti-hyperlipidemic | Hypercholesterolaemic male albino rats | 200mg/kg of the extract orally to rats | The Curcuma extract caused hypolipidemic effect in tested rats. | [106] |
C. zedoaria Roscoe | White turmeric or zedoary | Clinical study on human subjects | – | ↓Serum total cholesterol after 60 days Significant increase in HDL-cholesterol after two months. Pronounced decrease in serum LDL-cholesterol and triglycerides. | [105] |